Short answer
Regulatory monitoring should happen often enough that teams can act before the decision window closes. For high-risk substances, active markets, or fast-moving regimes, that usually means continuous or near-continuous monitoring. Lower-risk areas may be reviewed on a scheduled cadence, but the rationale should be explicit.
Cadence Follows Risk
A team tracking a substance under active restriction pressure needs a different cadence from a team watching a mature rule with stable guidance.
The right question is not how often monitoring feels reasonable. It is how much time the business needs to respond once an early signal appears.
Late Signals Are Expensive
Late detection can compress reformulation, customer communication, supplier qualification, labelling work, and leadership decision-making into the same window.
The practical value of more frequent monitoring is often the time it gives teams to think instead of fire-fighting.
Frequently asked questions
Is daily monitoring always necessary?
No. Daily or continuous monitoring is most useful where regulatory velocity and business exposure are high. Other areas may justify a lighter cadence.
Should monitoring cadence be documented?
Yes. A documented cadence makes the watch easier to defend and easier to improve after missed or late signals.
Related questions
What is regulatory monitoring?
The continuous watch for regulatory change, with enough context to decide what matters.
Read moreHow do regulatory teams avoid missing early signals?
Watch the lifecycle before the rule lands, not only the final publication.
Read moreWhat belongs in a regulatory audit trail?
An audit trail should make later review easier, not just prove that something happened.
Read more